[1] WANG Y, YI L, WANG Y X, et al. Isolation, phylogenetic group, drug resistance, biofilm formation, and adherence genes of Escherichia coli from poultry in central China[J]. Poult Sci, 2016, 95(12):2895-2901.
[2] CRISCUOLO E, SPADINI S, LAMANNA J, et al. Bacteriophages and their immunological applications against infectious threats[J]. J Immunol Res, 2017, 2017:3780697.
[3] CISEK A A, DABROWSKA I, GREGORCZYK K P, et al. Phage therapy in bacterial infections treatment:one hundred years after the discovery of bacteriophages[J]. Curr Microbiol, 2017, 74(2):277-283.
[4] YOUNG R. Phage lysis:three steps, three choices, one outcome[J]. J Microbiol, 2014, 52(3):243-258.
[5] BERTOZZI SILVA J, STORMS Z, SAUVAGEAU D. Host receptors for bacteriophage adsorption[J]. FEMS Microbiol Lett, 2016, 363(4):fnw002.
[6] RAKHUBA D V, KOLOMIETS E I, DEY E S, et al. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell[J]. Pol J Microbiol, 2010, 59(3):145-155.
[7] HEINRICHS D E, YETHON J A, WHITFIELD C. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica[J]. Mol Microbiol, 1998, 30(2):221-232.
[8] GONZÁLEZ-GARCÍA V A, PULIDO-CID M, GARCIA-DOVAL C, et al. Conformational changes leading to T7 DNA delivery upon interaction with the bacterial receptor[J]. J Biol Chem, 2015, 290(16):10038-10044.
[9] ROJAS-MACIAS M A, STÅHLE J, LVTTEKE T, et al. Development of the ECODAB into a relational database for Escherichia coli O-antigens and other bacterial polysaccharides[J]. Glycobiology, 2015, 25(3):341-347.
[10] NAKAO R, RAMSTEDT M, WAI S N, et al. Enhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesis[J]. PLoS One, 2012, 7(12):e51241.
[11] ZHANG C, LI W L, LIU W H, et al. T4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickens[J]. Appl Environ Microbiol, 2013, 79(18):5559-5565.
[12] WANG Z, WANG J L, REN G, et al. Influence of core oligosaccharide of lipopolysaccharide to outer membrane behavior of Escherichia coli[J]. Mar Drugs, 2015, 13(6):3325-3339.
[13] BOGDANOV M, MILEYKOVSKAYA E, DOWHAN W. Lipids in the assembly of membrane proteins and organization of protein supercomplexes:implications for lipid-linked disorders[J]. Subcell Biochem, 2008, 49:197-239.
[14] RAETZ C R H, WHITFIELD C. Lipopolysaccharide endotoxins[J]. Annu Rev Biochem, 2002, 71:635-700.
[15] DESROY N, MOREAU F, BRIET S, et al. Towards Gram-negative antivirulence drugs:new inhibitors of HldE kinase[J]. Bioorg Med Chem, 2009, 17(3):1276-1289.
[16] KARUNAKARAN E, MUKHERJEE J, RAMALINGAM B, et al. "Biofilmology":a multidisciplinary review of the study of microbial biofilms[J]. Appl Microbiol Biotechnol, 2011, 90(6):1869-1881.
[17] NAKAO R, SENPUKU H, WATANABE H. Porphyromonas gingivalis galE is involved in lipopolysaccharide O-Antigen synthesis and biofilm formation[J]. Infect Immun, 2006, 74(11):6145-6153.
[18] XU D, ZHANG W, ZHANG B, et al. Characterization of a biofilm-forming Shigella flexneri phenotype due to deficiency in Hep biosynthesis[J]. Peer J, 2016, 4:e2178.
[19] MITZEL M R, SAND S, WHALEN J K, et al. Hydrophobicity of biofilm coatings influences the transport dynamics of polystyrene nanoparticles in biofilm-coated sand[J]. Water Res, 2016, 92:113-120. |